Nuchal translucency and first trimester biochemical markers for down syndrome screening: A cost-effectiveness analysis

2002 ◽  
Vol 187 (5) ◽  
pp. 1239-1245 ◽  
Author(s):  
Aaron B. Caughey ◽  
Miriam Kuppermann ◽  
Mary E. Norton ◽  
A.Eugene Washington
Keyword(s):  
Down Syndrome ◽  
Cost Effectiveness ◽  
Biochemical Markers ◽  
First Trimester ◽  
Nuchal Translucency ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Down Syndrome Screening

A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome

2015 ◽  
Vol 35 (5) ◽  
pp. 440-446 ◽  
Author(s):  
Brandon S. Walker ◽  
Brian R. Jackson ◽  
Danielle LaGrave ◽  
Edward R. Ashwood ◽  
Robert L. Schmidt
Keyword(s):  
Down Syndrome ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Cell Free Dna ◽  
Free Dna ◽  
Effectiveness Analysis ◽  
Serum Screening

Impact of a shift in nuchal translucency measurements on the detection rate of first-trimester Down syndrome screening: A population-based study

2018 ◽  
Vol 38 (2) ◽  
pp. 106-109 ◽  
Author(s):  
Nicolas Fries ◽  
Laurent J. Salomon ◽  
Françoise Muller ◽  
Sophie Dreux ◽  
Véronique Houfflin-Debarge ◽  
...  
Keyword(s):  
Down Syndrome ◽  
Detection Rate ◽  
First Trimester ◽  
Nuchal Translucency ◽  
Population Based ◽  
Population Based Study ◽  
Down Syndrome Screening
Sign in / Sign up

Export Citation Format

Share Document